S
ABCL icon

SignatureFD’s AbCellera Biologics ABCL Stock Holding History

SignatureFD’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.6K Buy
10,138
+899
+10% +$4.39K ﹤0.01% 1581
2026
Q1 		$32.2K Sell
9,239
-1,225
-12% -$4.41K ﹤0.01% 1965
2025
Q4 		$35.8K Sell
10,464
-1,986
-16% -$8.87K ﹤0.01% 1841
2025
Q3 		$62.6K Buy
12,450
+3,019
+32% +$13.3K ﹤0.01% 1522
2025
Q2 		$32.3K Sell
9,431
-7,016
-43% -$17.5K ﹤0.01% 1824
2025
Q1 		$36.7K Sell
16,447
-41,019
-71% -$118K ﹤0.01% 1745
2024
Q4 		$168K Buy
57,466
+21,807
+61% +$60.7K ﹤0.01% 947
2024
Q3 		$92.7K Buy
35,659
+25,294
+244% +$70.1K ﹤0.01% 1253
2024
Q2 		$30.7K Sell
10,365
-751
-7% -$2.84K ﹤0.01% 1756
2024
Q1 		$50.4K Buy
11,116
+520
+5% +$2.65K ﹤0.01% 1553
2023
Q4 		$60.5K Buy
10,596
+7,988
+306% +$37K ﹤0.01% 1374
2023
Q3 		$12K Sell
2,608
-807
-24% -$4.91K ﹤0.01% 2104
2023
Q2 		$22.1K Buy
3,415
+2,876
+534% +$19.6K ﹤0.01% 1838
2023
Q1 		$4.06K Buy
539
+80
+17% +$726 ﹤0.01% 2587
2022
Q4 		$4.65K Buy
459
+187
+69% +$2.16K ﹤0.01% 2508
2022
Q3 		$3K Buy
+272
New +$2.98K ﹤0.01% 2593

Other funds holding ABCL

CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
HOWA
Heritage Oak Wealth Advisors Santa Rosa Beach, Florida $340M AUM 29.73% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
FA
Fedenia Advisers Madison, Wisconsin $421M AUM 96.46% 1-Year Est. Return

SignatureFD's ABCL Position: Q2 2026 in Review

SignatureFD increased its AbCellera Biologics (ABCL) stake by 9.7% in Q2 2026, buying an estimated $4.39K and bringing the position to 10,138 shares worth $79.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

SignatureFD first reported a position in ABCL in Q3 2022 and has held it in 16 quarters since. The position peaked at $168K in Q4 2024. 24 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • SignatureFD held 10,138 shares of AbCellera Biologics worth $79.6K as of Q2 2026.
  • SignatureFD bought 899 AbCellera Biologics shares in Q2 2026, an estimated $4.39K.
  • AbCellera Biologics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1581 holding.
  • SignatureFD first reported a position in AbCellera Biologics in Q3 2022 and has held it in 16 quarters since.
  • SignatureFD's AbCellera Biologics position peaked at $168K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.